C. Chang

发表

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.

B. Ueberheide, J. Moffat, C. Sotiriou, 2021, Cancer discovery.

Ontogeny and Vulnerabilities of Lapatinib Drug-Tolerant Persisters in HER2+ Breast Cancer

B. Ueberheide, J. Moffat, C. Sotiriou, 2020, bioRxiv.

Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.

B. Ueberheide, J. Moffat, C. Sotiriou, 2021, Cancer discovery.